| Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
|---|
| 04/15/2004 | US20040072202 Incorporating a base selected from the group consisting of 7-deazaguanosine, 2-aminopurine, 8-aza-7-deazaguanosine, 1H-purine, and hypoxanthine into the oligonuclotide of the oligonuleotide array |
| 04/15/2004 | US20040072194 Vasodilation polypeptide for diagnosis and treatment of vascular and cardiovascular system disorders |
| 04/15/2004 | US20040072191 Antisense RNA standardizing control |
| 04/15/2004 | US20040072190 Hydrolases |
| 04/15/2004 | US20040072188 Comprises nucleotide sequences coding B-cell activating factor receptor (BAFF-R) for diagnosis, prevention, treatment and/or delay of cancers, lymphomas and autoimmune diseases |
| 04/15/2004 | US20040072187 Comprises nucleotide sequences coding biogenic amine receptor for diagnosis, prevention and treatment of parkinson's, schizophrenia, attention deficit hyperactivity disorder |
| 04/15/2004 | US20040072179 Genetically engineered nuclear inclusion proteinase (NIa) comprising increased stability for obtaining large quantities of purified active proteins that form inclusion bodies in cells; modifying enzyme for premature polypeptides |
| 04/15/2004 | US20040072175 Comprises kinesin for identifying herbicides, insecticides or fungicides which improve food and/or fiber crop production |
| 04/15/2004 | US20040072173 Methods and materials relating to leucine-rich repeat protein-like (lrr protein-like) polypeptides and polynucleotides |
| 04/15/2004 | US20040072167 A dry composition comprising a nucleotide linked to a fluorescent dye ;a method of making the composition comprising drying the composition |
| 04/15/2004 | US20040072157 Heterotrimeric fusion protein comprising g protein coupled receptor specificity for identifying modulators and treatments of aberrent signal transduction |
| 04/15/2004 | US20040072151 Method of extracting virus genes and extraction apparatus |
| 04/15/2004 | US20040072150 Identification of oligonucleotides for the capture, detection and quantitation of hepatitis A viral nucleic acid |
| 04/15/2004 | CA2500955A1 Optimized multi-epitope constructs and uses thereof |
| 04/15/2004 | CA2499891A1 Multimeric protein engineering |
| 04/15/2004 | CA2499123A1 Ii-key/antigenic epitope hybrid peptide vaccines |
| 04/15/2004 | CA2498631A1 Use of a33 antigens and jam-it |
| 04/14/2004 | EP1408090A1 Dibenzorhodamine dyes useful as fluorescent labelling agents |
| 04/14/2004 | EP1407053A2 Dna microarrays comprising active chromatin elements and comprehensive profiling therewith |
| 04/14/2004 | EP1407051A2 Universal method and composition for the rapid lysis of cells for the release of nucleic acids and their detection |
| 04/14/2004 | EP1407044A2 Rna interference mediating small rna molecules |
| 04/14/2004 | EP1406667A2 METHODS FOR INCREASING i IN VIVO /i EFFICACY OF OLIGONUCLEOTIDES AND INHIBITING INFLAMMATION IN MAMMALS |
| 04/14/2004 | EP1366057A4 Reagents for oligonucleotide cleavage and deprotection |
| 04/14/2004 | EP1019361B1 Polyfunctional cationic cytofectins, formulations and methods for generating active cytofectin:polynucleotide transfection complexes |
| 04/14/2004 | CN1489633A Methods for detection of chloral hydrate in dichloroacetic acid |
| 04/14/2004 | CN1488642A Paddy rice ethylene receptor protein, coded gene and use thereof |
| 04/14/2004 | CN1488639A Method for separating RNA from tissue sample |
| 04/13/2004 | US6721663 Method for manipulating protein or DNA sequence data in order to generate complementary peptide ligands |
| 04/13/2004 | US6720488 Transgenic maize seed and method for controlling insect pests |
| 04/13/2004 | US6720411 Nanoparticles having oligonucleotides attached thereto and uses therefor |
| 04/13/2004 | US6720182 Alternative splice variants of CD40 |
| 04/13/2004 | US6720181 Ubiquitin ligases as therapeutic targets |
| 04/13/2004 | US6720174 Stabilizing amino acid mutations are introduced into a homologous protein, or the active site of a phytase is replaced in part or in toto. |
| 04/13/2004 | US6720148 Monitoring changes in fluorescent signal that occur during the polymerase-mediated extension of dye labeled primer molecules. |
| 04/13/2004 | US6720147 Generating genetically engineered nucleotide sequences; obtain nucleic acid, incubate with nanoparticles, join sequences and nanoparticles, recover and detect adjustment insequences |
| 04/13/2004 | US6719968 For therapy of tendinitis, or other tendon or ligament defect |
| 04/13/2004 | CA2261150C Methods for purifying nucleic acids |
| 04/13/2004 | CA2195076C Process for modifying the stability of antibodies |
| 04/13/2004 | CA2182397C Endotoxin reduction or removal process |
| 04/08/2004 | WO2004029297A1 Compositions and methods for the use of fmoc derivatives in dna/ rna synthesis |
| 04/08/2004 | WO2004029287A2 Polypeptides and nucleic acids encoding these and their use for the prevention, diagnosis or treatment of liver disorders and epithelial cancer |
| 04/08/2004 | WO2004029283A2 Subtelomeric dna probes and method of producing the same |
| 04/08/2004 | WO2004029281A2 Methods and compositions for rnai mediated inhibition of viral gene expression in mammals |
| 04/08/2004 | WO2004029278A2 Aav itr-mediated modulation |
| 04/08/2004 | WO2004029277A2 Oligonucleotide conjugates |
| 04/08/2004 | WO2004029274A2 Method for generating an immune response and reagents therefor |
| 04/08/2004 | WO2004029273A1 Production method of iturin a and its homologues |
| 04/08/2004 | WO2004029258A1 Nucleic acid constructs for gene expression |
| 04/08/2004 | WO2004029241A1 Method of amplifying nucleic acid by electromagnetic induction heating and reaction container and reaction device to be used therein |
| 04/08/2004 | WO2004029212A2 In vivo gene silencing by chemically modified and stable sirna |
| 04/08/2004 | WO2004029023A2 Cell-surface estrogen receptor and related compositions and methods |
| 04/08/2004 | WO2004028458A2 Antisense modulation of microsomal prostaglandin e2 synthase expression |
| 04/08/2004 | WO2004028342A2 Endogenous granzyme b in human non-hematopoietic cells |
| 04/08/2004 | WO2004018499A3 Synthetic heparin-binding growth factor analogs |
| 04/08/2004 | WO2004013155A3 Stabilisation of nucleic acids |
| 04/08/2004 | WO2004011624A9 Double stranded rna structures and constructs, and methods for generating and using the same |
| 04/08/2004 | WO2004011401A3 Method for making biochips |
| 04/08/2004 | WO2004009839A3 Oligonucleotides for detecting micro-organisms |
| 04/08/2004 | WO2004003139A3 Modified shine-dalgarno sequences and methods of use thereof |
| 04/08/2004 | WO2004002294A3 Plasma or serum marker and process for detection of cancer |
| 04/08/2004 | WO2003107144A3 Systems and methods for predicting oligonucleotide melting temperatures (tms) |
| 04/08/2004 | WO2003106684A3 A method for simultaneous production of multiple proteins; vectors and cells for use therein |
| 04/08/2004 | WO2003102185A3 Methods and compositions for treating neoplasia relating to hnrnp a1 and a2 nucleic acid molecules |
| 04/08/2004 | WO2003095976A3 Qm-7 and qt-6 cells transfected with mutant cell surface expressed channel receptors and assays using the transfected cells |
| 04/08/2004 | WO2003087021A3 Nanoparticle delivery systems and methods of use thereof |
| 04/08/2004 | WO2003080646A3 Modified plasminogen activator inhibitor type-1 and methods based thereon |
| 04/08/2004 | WO2003070974A3 Mismatch repair detection |
| 04/08/2004 | WO2003064469A3 Regulation of human hematopoietin receptor-like protein |
| 04/08/2004 | WO2003064468A3 The ligand binding pocket peptide fragment of estrogen-related receptor 3 (err3), its crystal structure, and uses thereof |
| 04/08/2004 | WO2003046581A3 Methods for diagnosis and treatment of epithelial-derived cancers,such as colorectal cancers and kidney cancers |
| 04/08/2004 | WO2003033646A8 Compositions and methods for the modulation of viral maturation |
| 04/08/2004 | WO2002097058A3 Genetic markers for improved disease resistance in animals (nramp1) |
| 04/08/2004 | WO2002083854A3 Antibodies to vla-1 |
| 04/08/2004 | WO2002045657A3 Ovarian tumor antigen and methods of use therefor |
| 04/08/2004 | US20040068098 Comprises nucleotide sequences coding neurotoxic stress related protein for diagnosis, prevention and treatment of neurodegenerative diseases; antisense and gene therapy |
| 04/08/2004 | US20040068097 Method and materials relating to g protein-coupled receptor-like polypeptides and polynucleotides |
| 04/08/2004 | US20040068096 Human single nucleotide polymorphisms in organic anion transport and multi-drug resistant proteins |
| 04/08/2004 | US20040067907 Process for delivery of polynucleotides to the prostate |
| 04/08/2004 | US20040067521 Sequence specific recognition reagents (oligonucleotide, monoclonal antibodies) attached to a solid substrate; sequencing, fingerprinting and mapping biological polymers |
| 04/08/2004 | US20040067519 Kit for amplifying and/or determining the molecular structure; labelled oligonucleotides; genotyping; patients with alleles encoding alanine at position 9 of the signal peptide has an increased risk; colorectal |
| 04/08/2004 | US20040067518 Isolated nucleic acid comprising a polynucleotide of given sequence; polypeptides; recombinant host cells; useful in diagnosing and treating disorders |
| 04/08/2004 | US20040067503 Functionalized nanoparticles and methods of use |
| 04/08/2004 | US20040067498 Detection of nucleic acid sequences by cleavage and separation of tag-containing structures |
| 04/08/2004 | US20040067490 Nucleic acid sequences, and antibodies that immunospecifically bind to the polypeptide, their derivatives, variants, mutants, or fragments of the novel polypeptide, polynucleotide, or antibody specific to the polypeptide |
| 04/08/2004 | DE10239585A1 New nucleic acid molecules, useful for detecting plant material, e.g. genetically modified material in food, are designed to amplify the chloroplast tRNA-Leu gene |
| 04/08/2004 | CA2500551A1 Subtelomeric dna probes and method of producing the same |
| 04/08/2004 | CA2500397A1 Aav itr-mediated modulation |
| 04/08/2004 | CA2500285A1 Compositions and methods for the use of fmoc derivatives in dna/rna synthesis |
| 04/08/2004 | CA2500270A1 Nucleic acid constructs for gene expression |
| 04/08/2004 | CA2500224A1 In vivo gene silencing by chemically modified and stable sirna |
| 04/08/2004 | CA2499082A1 Oligonucleotide conjugates for inhibiting telomerase enzyme activity |
| 04/08/2004 | CA2494899A1 Polypeptides and nucleic acids encoding these and their use for the prevention, diagnosis or treatment of liver disorders and epithelial cancer |
| 04/07/2004 | EP1405666A2 Substrate for methods to determine analytes and methods to manufacture such substrates |
| 04/07/2004 | EP1404878A1 Internal calibration standards for electrophoretic analyses |
| 04/07/2004 | EP1404873A2 Chimeric immunomodulatory compounds and methods of using the same |
| 04/07/2004 | EP1404871A2 Method for treatment of cancer associated with elevated her 2 levels |
| 04/07/2004 | EP1404860A2 Delivery system for nucleic acids |
| 04/07/2004 | EP1404843A2 Regulation of human nek-like serine/threonine protein kinase |
| 04/07/2004 | EP1404842A2 Perv screening method and use thereof |
| 04/07/2004 | EP1404702A2 Human secreted proteins |